The aim of this study is to to analyze if it is possible to reach the goals of HbA1c \<7.0% and blood pressure \<= 130/80 mm Hg in a cohort of patients with type 2 diabetes attending a primary care unit, using ony those resources available at the unit, and provided by the Brazilian National Health System. It is an open label, observational study, with a duration of 4-6 years. Patients attending a primary care outpatient facility will be sequentially included in the study provided they give consent. They will be followed on a monthly basis by a team of physicians and nurses. Glucose, A1c, Blood PRessure will be the outcomes.
Study Type
OBSERVATIONAL
Enrollment
124
850 mg TID
10 mg BID
Variable SC dose
25 mg QD introduced as initial therapy for hypertension
40 mg BID
50 mg TID
10 mg QD
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Glycated hemoglobin A1c
Time frame: 3 months
Blood pressure
Time frame: 1 month
24 hr blood glucose profile
Time frame: once
Fasting blood glucose
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.